IP Library › Granted Patent US 12,283,373
Granted Patent B2
US 12,283,373 · App. 18/507,383 · Granted Apr 22, 2025

Device and method for detecting an actuation action performable with a medical device

Inventors: Jasmin Groeschke (Frankfurt am Main, DE); Hanno Juhnke (Frankfurt am Main, DE); Jan-Peter Spengler (Frankfurt am Main, DE); Matthias Scharf (Frankfurt am Main, DE); Christoph Dette (Frankfurt am Main, DE); Michael Schrack (Pliezhausen, DE); Olaf Zeckai (Weinheim, DE)
Assignee: Sanofi-Aventis Deutschland GMBH
G16H40/40A61M5/31525A61M5/31533G16Z99/00A61M2005/3126A61M5/3135A61M2005/3142A61M2205/52A61M2205/581A61M2205/582A61M2205/583A61M2207/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,283,373
App. No.
18/507,383
Granted
Apr 22, 2025
Kind
B2
Abstract

An apparatus is disclosed, comprising a detector unit comprising a detector configured to detect an actuation action performable via the detector unit to an actuation button of a medical device to cause the medical device to eject at least a portion of a medicament comprised in the medical device. The detector is configured to detect the actuation action based on a detection of a force and/or a touch applied to the detector unit as part of the actuation action. The apparatus further comprises an electric unit connected to the detector and configured to store and/or provide information related to the detected actuation action. Furthermore, an according method and a computer program for controlling this method are disclosed.

Claims (32)

1. A monitoring apparatus for releasable attachment to a medicament delivery device, the monitoring apparatus comprising:

a housing;

an electric circuit arranged in the housing, the electric circuit configured to monitor one or more functions of the medicament delivery device;

an attachment unit configured to releasably attach the monitoring apparatus to the medicament delivery device, wherein the attachment unit comprises a plurality of arms configured to at least partially embrace an outer circumference of at least a portion of the medicament delivery device; and

a detector configured to detect an actuation action performed with the medicament delivery device.

2. The monitoring apparatus according to claim 1 , wherein the detector is arranged to be activated by an actuation element during performance of the actuation action to detect the actuation action.

3. The monitoring apparatus according to claim 1 , wherein the detector is arranged to detect the actuation action based on detection of an actuation force applied axially with respect to a longitudinal axis of the medicament delivery device.

4. The monitoring apparatus according to claim 1 , wherein the detector comprises a piezoelectric sensor.

5. The monitoring apparatus according to claim 1 , wherein the detector comprises an electric switch.

6. The monitoring apparatus according to claim 1 , wherein the actuation action is performable to an actuation button of the medicament delivery device.

7. The monitoring apparatus according to claim 6 , wherein the actuation action is performable to the actuation button of the medicament delivery device via the detector.

8. The monitoring apparatus according to claim 1 , wherein the actuation action is to cause the medicament delivery device to eject at least a portion of a medicament in the medicament delivery device.

9. The monitoring apparatus according to claim 1 , wherein the detector is arranged to activate the electric circuit responsive to detection of the actuation action.

10. The monitoring apparatus according to claim 1 , further comprising an LED configured to indicate information related to the actuation action.

11. The monitoring apparatus according to claim 10 , wherein the electric circuit is configured to cause the LED to be switched on responsive to the detector detecting the actuation action.

12. The monitoring apparatus according to claim 10 , wherein the electric circuit is configured to cause the LED to be switched on for a predetermined period of time.

13. The monitoring apparatus according to claim 1 , wherein the detector is comprised in a detector unit, and wherein the detector is configured to detect the actuation action based on detecting a movement and/or a deformation of at least a part of the detector unit caused by an actuation force.

14. The monitoring apparatus according to claim 1 , wherein the electric circuit is configured to determine a length of a time interval during which the actuation action is applied, and to store and/or provide information related to the determined length of said time interval and/or to store and/or provide information related to the actuation action in dependence on the determined length of the time interval.

15. The monitoring apparatus according to claim 1 , further comprising a dose determination unit configured to determine a dose of a medicament, wherein the dose determination unit is connected to the electric circuit, and wherein the electric circuit is further configured to store and/or provide information related to the determined dose.

16. The monitoring apparatus according to claim 15 , wherein the dose determination unit is configured to determine the dose by sensing sounds that occur when the medicament delivery device is operated, or by sensing a movement of a component of the medicament delivery device.

17. The monitoring apparatus according to claim 1 , wherein the electric circuit is further configured to provide information allowing for identifying the medicament delivery device.

18. A method comprising detecting, using a detector of a monitoring apparatus, an actuation action performed to a medicament delivery device, the monitoring apparatus configured for releasable attachment to the medicament delivery device and comprising:

a housing;

an electric circuit arranged in the housing, the electric circuit configured to monitor one or more functions of the medicament delivery device;

an attachment unit configured to releasably attach the monitoring apparatus to the medicament delivery device, the attachment unit comprising a plurality of arms configured to at least partially embrace an outer circumference of at least a portion of the medicament delivery device; and

the detector.

19. One or more non-transitory computer readable storage media comprising one or more instructions that, once executed by one or more processors of a detector of a monitoring apparatus, cause the detector to perform operations, the operations comprising:

detecting an actuation action performed to a medicament delivery device, the monitoring apparatus configured for releasable attachment to the medicament delivery device and comprising:

a housing;

an electric circuit arranged in the housing, the electric circuit configured to monitor one or more functions of the medicament delivery device;

an attachment unit configured to releasably attach the monitoring apparatus to the medicament delivery device, the attachment unit comprising a plurality of arms configured to at least partially embrace an outer circumference of at least a portion of the medicament delivery device; and

the detector.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2023
From: GROESCHKE, JASMIN; JUHNKE, HANNO; SPENGLER, JAN-PETER; SCHARF, MATTHIAS; DETTE, CHRISTOPH; SCHRACK, MICHAEL; ZECKAI, OLAF
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 065550/0014 →
Priority Claims (1)
EP 11159593 · Mar 24, 2011 · regional
Continuity (4)
Continuation 17319508 · May 13, 2021
Continuation 16572242 · Sep 16, 2019
Continuation 14005877
Related Publication 20240087734A1 · Mar 14, 2024
References Cited (276)
US 533575A · Wilkens · 1895 [cited by applicant]
US 4959056A · Dombrowski et al. · 1990 [cited by applicant]
US 5112317A · Michel · 1992 [cited by applicant]
US 5226895A · Harris · 1993 [cited by applicant]
US 5279586A · Balkwill · 1994 [cited by applicant]
US 5304152A · Sams · 1994 [cited by applicant]
US 5320609A · Haber et al. · 1994 [cited by applicant]
US 5331953A · Andersson et al. · 1994 [cited by applicant]
US 5383865A · Michel · 1995 [cited by applicant]
US 5480387A · Gabriel et al. · 1996 [cited by applicant]
US 5505704A · Pawelka et al. · 1996 [cited by applicant]
US 5509905A · Michel · 1996 [cited by applicant]
US 5582598A · Chanoch · 1996 [cited by applicant]
US 5626566A · Petersen et al. · 1997 [cited by applicant]
US 5662612A · Niehoff · 1997 [cited by applicant]
US 5674204A · Chanoch · 1997 [cited by applicant]
US 5688251A · Chanoch · 1997 [cited by applicant]
US 5921966A · Bendek et al. · 1999 [cited by applicant]
US 5961495A · Walters et al. · 1999 [cited by applicant]
US 6004297A · Steenfeldt-Jensen et al. · 1999 [cited by applicant]
US 6193698B1 · Kirchhofer et al. · 2001 [cited by applicant]
US 6221046B1 · Burroughs et al. · 2001 [cited by applicant]
US 6235004B1 · Steenfeldt-Jensen et al. · 2001 [cited by applicant]
US 6246322B1 · LeDain et al. · 2001 [cited by applicant]
US 6248095B1 · Giambattista et al. · 2001 [cited by applicant]
US 6277099B1 · Strowe et al. · 2001 [cited by applicant]
US 6482185B1 · Hartmann · 2002 [cited by applicant]
US 6500169B1 · Deng · 2002 [cited by applicant]
US 6585698B1 · Packman et al. · 2003 [cited by applicant]
US 6620133B1 · Steck · 2003 [cited by applicant]
US 6869413B2 · Langley et al. · 2005 [cited by applicant]
US 6899698B2 · Sams · 2005 [cited by applicant]
US 6936032B1 · Bush, Jr. et al. · 2005 [cited by applicant]
US 7008399B2 · Larsen et al. · 2006 [cited by applicant]
US 7241278B2 · Moller · 2007 [cited by applicant]
US 7749186B2 · Kohlbrenner et al. · 2010 [cited by applicant]
US 8052655B2 · Moller et al. · 2011 [cited by applicant]
US 8197449B2 · Nielsen et al. · 2012 [cited by applicant]
US 8231573B2 · Edwards et al. · 2012 [cited by applicant]
US 8556847B2 · Kohlbrenner et al. · 2013 [cited by applicant]
US 8556865B2 · Krulevitch et al. · 2013 [cited by applicant]
US 8556866B2 · Krulevitch et al. · 2013 [cited by applicant]
US 8556867B2 · Krulevitch et al. · 2013 [cited by applicant]
US 8560271B2 · Koehler et al. · 2013 [cited by applicant]
US 8613719B2 · Karratt et al. · 2013 [cited by applicant]
US 8672899B2 · Diller et al. · 2014 [cited by applicant]
US 8771238B2 · Nielsen et al. · 2014 [cited by applicant]
US 8994382B2 · Nielsen et al. · 2015 [cited by applicant]
US 9289559B2 · Pedersen et al. · 2016 [cited by applicant]
US 9522238B2 · Nielsen et al. · 2016 [cited by applicant]
US 9526842B2 · Oh et al. · 2016 [cited by applicant]
US 9623188B2 · Nielsen et al. · 2017 [cited by applicant]
US 9649448B2 · Madsen · 2017 [cited by applicant]
US 9672328B2 · Saint et al. · 2017 [cited by applicant]
US 9734302B2 · Nielsen et al. · 2017 [cited by applicant]
US 9959391B2 · Saint et al. · 2018 [cited by applicant]
US 10105489B2 · Edwards et al. · 2018 [cited by applicant]
US 10213554B2 · Andersen et al. · 2019 [cited by applicant]
US 10383996B2 · Miller et al. · 2019 [cited by applicant]
US 10420895B2 · Erbstein et al. · 2019 [cited by applicant]
US 10471213B2 · Schabbach et al. · 2019 [cited by applicant]
US 10483000B2 · Saint et al. · 2019 [cited by applicant]
US 10593232B2 · Bauss · 2020 [cited by applicant]
US 10617827B2 · Hautaviita et al. · 2020 [cited by applicant]
US 10695504B2 · Nielsen et al. · 2020 [cited by applicant]
US 10857304B2 · Byerly · 2020 [cited by applicant]
US 10874802B2 · Toporek et al. · 2020 [cited by applicant]
US 11020533B2 · Erbstein et al. · 2021 [cited by applicant]
US 11278677B2 · Erbstein et al. · 2022 [cited by applicant]
US 11439762B2 · Toporek et al. · 2022 [cited by applicant]
US 11511047B2 · Toporek et al. · 2022 [cited by applicant]
US 11730891B2 · Toporek et al. · 2023 [cited by applicant]
US 11944796B2 · Toporek et al. · 2024 [cited by applicant]
US 12070584B2 · Erbstein et al. · 2024 [cited by applicant]
US 20020052578A1 · Moller · 2002 [cited by applicant]
US 20020120235A1 · Enggaard · 2002 [cited by applicant]
US 20020123716A1 · VanDiver et al. · 2002 [cited by applicant]
US 20020143288A1 · Larsen et al. · 2002 [cited by applicant]
US 20020163435A1 · Kosaka · 2002 [cited by applicant]
US 20020188419A1 · Slate et al. · 2002 [cited by applicant]
US 20030036762A1 · Kerr et al. · 2003 [cited by applicant]
US 20030050609A1 · Sams · 2003 [cited by applicant]
US 20030139706A1 · Gray · 2003 [cited by applicant]
US 20030208113A1 · Mault et al. · 2003 [cited by applicant]
US 20040059299A1 · Moller · 2004 [cited by applicant]
US 20040085215A1 · Moberg et al. · 2004 [cited by applicant]
US 20040140972A1 · Hirota et al. · 2004 [cited by applicant]
US 20040210199A1 · Atterbury et al. · 2004 [cited by applicant]
US 20040254539A1 · Wolbring et al. · 2004 [cited by applicant]
US 20040267207A1 · Veasey et al. · 2004 [cited by applicant]
US 20050080384A1 · Green · 2005 [cited by applicant]
US 20050113765A1 · Veasey et al. · 2005 [cited by applicant]
US 20050151652A1 · Frasch · 2005 [cited by applicant]
US 20050182323A1 · Grispo et al. · 2005 [cited by applicant]
US 20050192530A1 · Castellano · 2005 [cited by applicant]
US 20050283065A1 · Babayoff · 2005 [cited by applicant]
US 20060135907A1 · Remde et al. · 2006 [cited by applicant]
US 20060153693A1 · Fiechter et al. · 2006 [cited by applicant]
US 20070123829A1 · Atterbury et al. · 2007 [cited by applicant]
US 20070210828A1 · Won et al. · 2007 [cited by applicant]
US 20070265579A1 · Kleyman · 2007 [cited by examiner]
US 20080033369A1 · Kohlbrenner et al. · 2008 [cited by applicant]
US 20080058612A1 · Ohyu · 2008 [cited by examiner]
US 20080262469A1 · Brister et al. · 2008 [cited by applicant]
US 20090043253A1 · Podaima · 2009 [cited by applicant]
US 20090069742A1 · Larsen · 2009 [cited by applicant]
US 20090194104A1 · Van Sickle · 2009 [cited by applicant]
US 20090275916A1 · Harms et al. · 2009 [cited by applicant]
US 20100114026A1 · Karratt et al. · 2010 [cited by applicant]
US 20100324496A1 · Plumptre et al. · 2010 [cited by applicant]
US 20110037586A1 · Lu · 2011 [cited by examiner]
US 20110112474A1 · Bochenko et al. · 2011 [cited by applicant]
US 20110238017A1 · Watanabe et al. · 2011 [cited by applicant]
US 20110270214A1 · Jorgensen et al. · 2011 [cited by applicant]
US 20110313349A1 · Krulevitch et al. · 2011 [cited by applicant]
US 20120092670A1 · Chatow et al. · 2012 [cited by applicant]
US 20130197445A1 · Schabbach et al. · 2013 [cited by applicant]
US 20130204227A1 · Bochenko et al. · 2013 [cited by applicant]
US 20130274680A1 · Veasey et al. · 2013 [cited by applicant]
US 20130310756A1 · Whalley et al. · 2013 [cited by applicant]
US 20140194826A1 · Nielsen et al. · 2014 [cited by applicant]
US 20140194829A1 · Baek et al. · 2014 [cited by applicant]
US 20150018775A1 · Groeschke et al. · 2015 [cited by applicant]
US 20150202375A1 · Schabbach et al. · 2015 [cited by applicant]
US 20160235925A1 · Kuhn et al. · 2016 [cited by applicant]
US 20170182258A1 · Michael · 2017 [cited by applicant]
US 20170189625A1 · Cirillo et al. · 2017 [cited by applicant]
US 20170270276A1 · Saint et al. · 2017 [cited by applicant]
US 20170368263A1 · Ploch · 2017 [cited by applicant]
US 20180001027A1 · Klemm et al. · 2018 [cited by applicant]
US 20180008778A1 · Erbstein et al. · 2018 [cited by applicant]
US 20180154086A1 · Toporek et al. · 2018 [cited by applicant]
US 20190381248A1 · Erbstein et al. · 2019 [cited by applicant]
US 20200147315A1 · Toporek et al. · 2020 [cited by applicant]
US 20200197614A1 · Erbstein et al. · 2020 [cited by applicant]
US 20200353176A1 · Toporek et al. · 2020 [cited by applicant]
US 20200384205A1 · Toporek et al. · 2020 [cited by applicant]
US 20220001111A1 · Toporek et al. · 2022 [cited by applicant]
US 20220134009A1 · Erbstein et al. · 2022 [cited by applicant]
US 20220246290A1 · Groeschke et al. · 2022 [cited by applicant]
US 20220254484A1 · Groeschke et al. · 2022 [cited by applicant]
US 20230256175A1 · Toporek et al. · 2023 [cited by applicant]
US 20240066234A1 · Toporek et al. · 2024 [cited by applicant]
US 20240382688A1 · Erbstein et al. · 2024 [cited by applicant]
CN 101727540 · 2010 [cited by applicant]
CN 102413855 · 2012 [cited by applicant]
CN 102413856 · 2012 [cited by applicant]
CN 102458514 · 2012 [cited by applicant]
CN 103458945 · 2013 [cited by applicant]
CN 103561801 · 2014 [cited by applicant]
CN 103648555 · 2014 [cited by applicant]
CN 103702699 · 2014 [cited by applicant]
CN 104203315 · 2014 [cited by applicant]
CN 104245020 · 2014 [cited by applicant]
CN 104363940 · 2015 [cited by applicant]
CN 104411349 · 2015 [cited by applicant]
DE 29904864 · 2000 [cited by applicant]
DE 102004063664 · 2006 [cited by applicant]
EP 0777123 · 1997 [cited by applicant]
EP 0937471 · 1999 [cited by applicant]
EP 0937476 · 1999 [cited by applicant]
EP 2060284 · 2009 [cited by applicant]
EP 2182456 · 2010 [cited by applicant]
EP 2692378 · 2014 [cited by applicant]
EP 2762184 · 2014 [cited by applicant]
EP 3304372 · 2018 [cited by applicant]
EP 2401012 · 2020 [cited by applicant]
EP 2689359 · 2020 [cited by applicant]
JP H11267207 · 1999 [cited by applicant]
JP 2000506030 · 2000 [cited by applicant]
JP 2001087386 · 2001 [cited by applicant]
JP 2001509426 · 2001 [cited by applicant]
JP 2004523282 · 2004 [cited by applicant]
JP 2008516711 · 2008 [cited by applicant]
JP 2009530002 · 2009 [cited by applicant]
JP 2010534085 · 2010 [cited by applicant]
JP 2012500695 · 2012 [cited by applicant]
JP 2012504440 · 2012 [cited by applicant]
JP 2012135594 · 2012 [cited by applicant]
JP 2012519025 · 2012 [cited by applicant]
JP 2012519028 · 2012 [cited by applicant]
JP 2014516599 · 2014 [cited by applicant]
JP 2014520584 · 2014 [cited by applicant]
JP 2014533537 · 2014 [cited by applicant]
WO WO1990009202 · 1990 [cited by applicant]
WO WO1993016743 · 1993 [cited by applicant]
WO WO1997030742 · 1997 [cited by applicant]
WO WO1999002210 · 1999 [cited by applicant]
WO WO1999038554 · 1999 [cited by applicant]
WO WO2001010484 · 2001 [cited by applicant]
WO WO2002058767 · 2002 [cited by applicant]
WO WO2002064196 · 2002 [cited by applicant]
WO WO2006045525 · 2006 [cited by applicant]
WO WO2007107564 · 2007 [cited by applicant]
WO WO2009013736 · 2009 [cited by applicant]
WO WO2009083600 · 2009 [cited by applicant]
WO WO2010023303 · 2010 [cited by applicant]
WO WO2010023303A1 · 2010 [cited by examiner]
WO WO2010037828 · 2010 [cited by applicant]
WO WO2010052275 · 2010 [cited by applicant]
WO WO2010098927 · 2010 [cited by applicant]
WO WO2010098928 · 2010 [cited by applicant]
WO WO2010098931 · 2010 [cited by applicant]
WO WO2010128493 · 2010 [cited by applicant]
WO WO2010128493A2 · 2010 [cited by examiner]
WO WO2010142598 · 2010 [cited by applicant]
WO WO2012046199 · 2012 [cited by applicant]
WO WO2012118687 · 2012 [cited by applicant]
WO WO2012127046 · 2012 [cited by applicant]
WO WO2012130703 · 2012 [cited by applicant]
WO WO2012140097 · 2012 [cited by applicant]
WO WO2013004844 · 2013 [cited by applicant]
WO WO2013072445 · 2013 [cited by applicant]
WO WO2013120774 · 2013 [cited by applicant]
WO WO2013120776 · 2013 [cited by applicant]
WO WO2013120777 · 2013 [cited by applicant]
WO WO2013120778 · 2013 [cited by applicant]
WO WO2013177135 · 2013 [cited by applicant]
WO WO2014023763 · 2014 [cited by applicant]
WO WO2014037331 · 2014 [cited by applicant]
WO WO2014064691 · 2014 [cited by applicant]
WO WO2014111337 · 2014 [cited by applicant]
WO WO2014128156 · 2014 [cited by applicant]
WO WO2014153599A1 · 2014 [cited by applicant]
WO WO2014173768 · 2014 [cited by applicant]
WO WO2014173774 · 2014 [cited by applicant]
WO WO2014180744 · 2014 [cited by applicant]
WO WO2014180745 · 2014 [cited by applicant]
WO WO2016131713 · 2016 [cited by applicant]
WO WO2016193229 · 2016 [cited by applicant]
WO WO2019173097 · 2019 [cited by applicant]
[No Author Listed], “Comparison of publication EP201012B1 with publication WO2010/098928,” cited in European Opposition in EP Application No. 16729241.6, unknown date, 26 pages. [cited by applicant]
[No.. Author Listed], “HumaPen Ergo Manual”, Eli Lilly and Company Ltd., 2003, 2 pages. [cited by applicant]
[No.. Author Listed], “Technical Dossier for the HumaPen Pen-Injector Family,” Eli Lilly & Company—Pharmaceutical Delivery Systems, Aug. 15, 2000, 17 pages. [cited by applicant]
Brief Communication in European Application No. 12710104.6, dated Jan. 20, 2022, 70 pages. [cited by applicant]
Brief Communication in European Application No. 12710104.6, dated Jan. 9, 2023, 47 pages. [cited by applicant]
Brief Communication in European Application No. 12710104.6, dated May 6, 2022, 37 pages. [cited by applicant]
Brief Communication in European Application No. 16704003.9, dated Jan. 21, 2022, 81 pages. [cited by applicant]
Brief Communication in European Application No. 16704003.9, dated May 3, 2022, 152 pages. [cited by applicant]
Brief Communication in European Application No. 16729241.6, dated Apr. 11, 2022, 28 pages. [cited by applicant]
Brief Communication in European Application No. 16729241.6, dated Apr. 7, 2022, 11 pages. [cited by applicant]
Brief Communication in European Application No. 16729241.6, dated Apr. 7, 2022, 22 pages. [cited by applicant]
Brief Communication in European Appln. No. 12710104.6, dated Mar. 13, 2023, 13 pages. [cited by applicant]
Decision Rejecting the Opposition in European Application No. 12710104.6, dated May 11, 2023, 62 pages. [cited by applicant]
dictionary.cambridge.org [online], “Button,” 2014, retrieved on Jan. 3, 2022, retrieved from URL <https://dictionary.cambridge.org/de/worterbuch/englisch/button>, 11 pages. [cited by applicant]
EP Extended Search Report in European Patent Application No. 15171252.8, dated Dec. 9, 2015, 7 pages. [cited by applicant]
EP Notice of Opposition by Di-Care Zrt. in Patent Application No. 16704003.9, dated Aug. 27, 2021, 33 pages. [cited by applicant]
EP Notice of Opposition by Di-Care Zrt. in Patent Application No. 16729241.6, dated Feb. 8, 2021, 17 pages. [cited by applicant]
EP Notice of Opposition by Ferring International Center S.A. in Patent Application No. 9737825.1, dated Jun. 18, 2013, 22 pages. [cited by applicant]
EP Notice of Opposition by Herzog IP Patentanwalts GmbH in Patent Application No. 12710104.6, dated Aug. 31, 2021, 50 pages. [cited by applicant]
EP Notice of Opposition by Herzog IP Patentanwalts GMbH in Patent Application No. 16704003.9, dated Aug. 31, 2021, 126 pages. [cited by applicant]
EP Reply to a Submission in Opposition by Herzog IP Patentanwalts GMbH in Patent Application No. 12710104.6, dated Jan. 27, 2023, 162 pages. [cited by applicant]
EP Response to Communication in Opposition by Herzog IP Patentanwalts GMbH in Patent Application No. 16704003.9, dated Jun. 19, 2019, 7 pages. [cited by applicant]
EP Search Report for European Application No. 12710104.6, dated Sep. 21, 2017. [cited by applicant]
EP Search Report in European Patent Application No. 15155758.4, dated Sep. 4, 2015, 3 pages. [cited by applicant]
Examination Report in European Appln. No. 12710104.6, dated Sep. 21, 2017, 6 pages. [cited by applicant]
Interlocutory decision in Opposition Proceedings in European Application No. 16729241.6, dated Sep. 22, 2022, 231 pages. [cited by applicant]
International Preliminary Report on Patentability in Application No. PCT/EP2012/055252, dated Sep. 24, 2013, 9 pages. [cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/EP2016/052987, dated Aug. 22, 2017, 7 pages. [cited by applicant]
International Preliminary Report on Patentability in International Appln. No. PCT/EP2016/063139, dated Dec. 12, 2017, 7 pages. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/EP2016/052987, dated Apr. 21, 2016, 10 pages. [cited by applicant]
International Search Report and Written Opinion in International Appln. No. PCT/EP2016/063139, dated Sep. 22, 2016, 12 pages. [cited by applicant]
International Search Report for International Application No. PCT/EP2012/055252, completed Oct. 31, 2012. [cited by applicant]
[cited by applicant]
Novo Nordisk, “How to use NovoPen® 4,” [No Publication Date Listed], 2 pages (English version). [cited by applicant]
Novo Nordisk, “Instruction Manual for the NovoPen® 4,” 2004, 17 pages (Polish version). [cited by applicant]
Novo Nordisk, “Instruction Manual for the NovoPen® 4,” 2004, 19 pages (Danish version). [cited by applicant]
OnDrugDelivery, “Delivering Injectables: Devices & Device Components,” ONdrugDelivery Ltd., 2007, 20 pages. [cited by applicant]
Pearson et al., “Practical Aspects of Insulin Pen Devices,” Journal of Diabetes Science and Technology, May 2010, 4(3):522-531. [cited by applicant]
Reply to Examination Report in European Appln. No. 12710104.6, dated Jun. 29, 2018, 6 pages. [cited by applicant]
Rustige, “Important New Safety Reminder Regarding the HumaPen Ergo”, HumaPen Ergo Customer letter from Eli Lilly Canada, Dec. 11, 2001, 2 pages. [cited by applicant]
Written Submission in European Opposition in European Application No. 16729241.6, dated Apr. 4, 2022, 30 pages. [cited by applicant]
youtube.com [online], “Diabetes Education: How to Inject Insulin, ” available online as of Nov. 14, 2014, URL:<https://www.youtube.com/watch?v=ycp7BbFhG44>, 1 page [Video Submission]. [cited by applicant]
youtube.com [online], “How to use SoloStar Pen for Injecting Lantus (Glargine) and Apidra (Glulisine) Insulin Music Version,” available online as of May 17, 2013, URL:<https://www.youtube.com/watch?v=ZcfKG0Mp3kI>, 1 pag… [cited by applicant]
youtube.com [online], “Injecting Insulin With the Lantus SoloSTAR Pen,” available online as of Oct. 29, 2012, URL:<https://www.youtube.com/watch?v=g7JLG36ZO-U>, 2012, 1 page [Video Submission]. [cited by applicant]
youtube.com [online], “NovoPen 5—Novo Nordisk,” Youtube, Jul. 5, 2012, retrieved on Sep. 10, 2021, <https://www.youtube.com/watch?v=u3EX_0KzkQE>, 1 page [Video Submission]. [cited by applicant]
Cited By (1)
US 12,629,478